Quick Takeaways
- ARENA PHARMACEUTICALS INC has 15 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 15 Insiders of ARENA PHARMACEUTICALS INC
- Location
- San Diego, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 07 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
ARENA PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Robert Lisicki | EVP, Chief Commercial Officer | Mixed | 11 Mar 2022 | |||
| Garry Arthur Neil | Director | Mixed | 11 Mar 2022 | |||
| Jayson Donald Alexander Dallas | Director | Mixed | 11 Mar 2022 | |||
| Tina S. Nova | Director | Mixed | 11 Mar 2022 | |||
| Nawal Ouzren | Director | Mixed | 11 Mar 2022 | |||
| Kieran Gallahue | Director | Mixed | 11 Mar 2022 | |||
| Joan Schmidt | EVP, General Counsel & Sec | Mixed | 11 Mar 2022 | |||
| Vincent Aurentz | Executive VP and CBO | Mixed | 11 Mar 2022 | |||
| Katharine Knobil | Director | Mixed | 11 Mar 2022 | |||
| Steven J. Schoch | Director | Mixed | 11 Mar 2022 | |||
| Oliver Fetzer | Director | Mixed | 11 Mar 2022 | |||
| Amit Munshi | President and CEO, Director | Mixed | 11 Mar 2022 | |||
| Laurie Stelzer | EVP & Chief Financial Officer | Mixed | 11 Mar 2022 | |||
| Douglas J. Manion | EVP Research & Development | Mixed | 11 Mar 2022 | |||
| Jennifer Jarrett | Director | Mixed | 11 Mar 2022 |
Top shareholders of ARENA PHARMACEUTICALS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Recent Insider Transactions by Companies or Individuals for ARENA PHARMACEUTICALS INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.